Development and validation of UV-spectrophotometric methods for quantitative estimation of Prothionamide in pure and pharmaceutical dosage forms

Authors

  • Sujit Kumar Debnath N. R. Vekaria Institute of Pharmacy Junagadh, Gujarat-362001
  • S. Saisivam N. R. Vekaria Institute of Pharmacy Junagadh, Gujarat-362001
  • Dillip Kumar Dash N. R. Vekaria Institute of Pharmacy Junagadh, Gujarat-362001
  • Monalisha Debnath N. R. Vekaria Institute of Pharmacy Junagadh, Gujarat-362001

DOI:

https://doi.org/10.3329/icpj.v4i7.23590

Keywords:

Prothionamide, validation, UV-Spectrophometry, antitubercular drug, content determination

Abstract

UV Spectrophotometric method was developed and validated for the quantitative determination of Prothionamide in bulk drug and in pharmaceutical formulations. Prothionamide shows the maximum absorbance at 288 nm in phosphate buffer (pH 7.4). Prothionamide follows Beers law in the concentration range of 4-20 µg/ml (r2 = 0.999). The detection limit (DL) and quantitation limit (QL) were 0.406 and 1.229 µg/ml respectively. Accuracy and precision were found to be satisfactory. The developed methods were validated according to ICH guidelines. All the validation parameters were found to be satisfactory accordance with the standard values. Therefore, the proposed method can be used for routine practice for the determination of Prothionamide in assay of bulk drug and pharmaceutical formulations.

International Current Pharmaceutical Journal, June 2015, 4(7): 402-404

Downloads

Download data is not yet available.
Abstract
154
PDF
125

Downloads

Published

2015-06-06

How to Cite

Debnath, S. K., Saisivam, S., Dash, D. K., & Debnath, M. (2015). Development and validation of UV-spectrophotometric methods for quantitative estimation of Prothionamide in pure and pharmaceutical dosage forms. International Current Pharmaceutical Journal, 4(7), 402–404. https://doi.org/10.3329/icpj.v4i7.23590

Issue

Vol. 4 No. 7 (2015)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).